SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458508094401v1
14/9/1199    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sanna, A
Right arrow Articles by Sotgiu, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanna, A
Right arrow Articles by Sotgiu, S
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Herpes Simplex
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1

A Sanna

Department of Neuroscience, Institute of Clinical Neurology, University of Sassari, Sassari, Italy alexsanna72{at}yahoo.it

YM Huang

Department of Neuroscience, Neurology, Uppsala University Hospital, 751 85 Uppsala, Sweden

G Arru

Department of Neuroscience, Institute of Clinical Neurology, University of Sassari, Sassari, Italy

ML Fois

Department of Neuroscience, Institute of Clinical Neurology, University of Sassari, Sassari, Italy

H Link

Department of Neurology, Karolinska Institute, 141 86 Stockholm, Sweden

G Rosati

Department of Neuroscience, Institute of Clinical Neurology, University of Sassari, Sassari, Italy

S Sotgiu

Department of Neuroscience, Institute of Clinical Neurology, University of Sassari, Sassari, Italy

Objective

We hypothesized that autoaggressive immune responses observed in multiple sclerosis (MS) could be associated with an imbalance in proportion of immune cell subsets and in cytokine production in response to infection, including viruses.

Methods

We collected blood mononuclear cells (MNC) from 23 patients with MS and 23 sex- and age-matched healthy controls (HC) from the island of Sardinia, Italy, where the prevalence of MS is extraordinarily high. Using flow cytometry, we studied MNC for expression of blood dendritic cell antigens (BDCA)-2 and BDCA-4 surface markers reflecting the proportion of plasmacytoid dendritic cells (pDC) that produce type I interferons (IFNs) after virus challenge and promote Th2/anti-inflammtory cytokine production. In parallel, pro-inflammatory (interleukin [IL]-2, IL-12, IFN-{gamma}), anti-inflammatory (IL-4, IL-10), and immuno-regulatory/pleiotropic cytokines (type I IFNs including IFN-{alpha} and β, IL-6) were measured before and after an in vitro exposure to herpes simplex virus type 1 (HSV-1).

Results

The subset of lineage negative (lin), BDCA-2+ cells was lower in patients with MS compared with HC (0.08 ± 0.02% vs 0.24 ± 0.02%; P < 0.001). A similar pattern was observed for linBDCA-4+ cells (0.08 ± 0.02% vs 0.17% ± 0.03; P < 0.01). Spontaneous productions of IL-6 (45 ± 10 pg/mL vs 140 ± 26 pg/mL; P < 0.01) and IL-10 (17 ± 0.4 pg/mL vs 21 ± 1 pg/mL; P < 0.05) by MNC were lower in patients with MS compared with HC. Spontaneous production of IL-6 (6.5 ± 0.15 pg/mL vs 21 ± 5 pg/mL; P < 0.01 and IL-10 (11 ± 1 pg/mL vs 14 ± 3 pg/mL; P < 0.05) by pDC was also lower in patients with MS compared with HC. Exposure of MNC to HSV-1 showed, in both patients with MS and HC, increased production of IFN-{alpha}, IL-6, and IL-10 but decreased production of IL-4. In response to HSV-1 exposure, productions of IL-6 (165 ± 28 pg/mL vs 325 ± 35 pg/mL; P < 0.01) and IL-10 (27 ± 3 vs 33 ± 3 P < 0.05) by MNC as well as by pDC (IL-6: 28 ± 7 vs 39 ± 12 P < 0.05; IL-10: 14 ± 1 vs 16 ± 3 P < 0.05) were lower in patients with MS compared with HC.

Conclusion

The results implicate a new evidence for altered immune cells and reduced immune responses in response to viral challenge in MS.

Key Words: herpes simplex virus • IL-6 • IL-12 • multiple sclerosis • plasmacytoid dendritic cells

This version was published on November 1, 2008

Multiple Sclerosis, Vol. 14, No. 9, 1199-1207 (2008)
DOI: 10.1177/1352458508094401


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement